[4] Liver enzymes (ALT, AST): While GLP-1medications are not known to cause liver injury and are generally safe in people without advanced liver disease, baseline liver tests may be obtained to evaluate overall metabolic health
Combating cellular senescence by sirtuins: implications for atherosclerosis
Consumers using GLP-1 medications are seeking more products with protein, fiber and healthy fats while reducing purchases of products high in carbohydrates and sugar, creating potential implications across grocery aisles, pharmacies, product portfolios, merchandising strategies and shopper engagement
Gross JL, Zelmanovitz T, Oliveira J, de Azevedo MJ
Long-term planning As you approach your goals, your provider works with you on a sustainable maintenance strategy to help preserve your results
PMID: 18985472